Edwards Lifesciences Corp. (EW)
103.27
-0.61
(-0.59%)
USD |
NYSE |
Nov 20, 10:36
Edwards Lifesciences Free Cash Flow : 1.424B for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.424B |
| June 30, 2026 | 1.434B |
| March 31, 2026 | 1.090B |
| December 31, 2025 | 1.335B |
| September 30, 2025 | 799.60M |
| June 30, 2025 | 577.90M |
| March 31, 2025 | 623.10M |
| December 31, 2024 | 259.90M |
| September 30, 2024 | 490.10M |
| June 30, 2024 | 551.80M |
| March 31, 2024 | 238.10M |
| December 31, 2023 | 629.50M |
| September 30, 2023 | 774.90M |
| June 30, 2023 | 668.70M |
| March 31, 2023 | 985.40M |
| December 31, 2022 | 953.40M |
| September 30, 2022 | 1.040B |
| June 30, 2022 | 1.261B |
| March 31, 2022 | 1.428B |
| December 31, 2021 | 1.402B |
| September 30, 2021 | 1.409B |
| June 30, 2021 | 1.051B |
| March 31, 2021 | 716.70M |
| December 31, 2020 | 647.00M |
| September 30, 2020 | 688.40M |
| Date | Value |
|---|---|
| June 30, 2020 | 936.80M |
| March 31, 2020 | 1.083B |
| December 31, 2019 | 901.00M |
| September 30, 2019 | 808.50M |
| June 30, 2019 | 704.50M |
| March 31, 2019 | 522.50M |
| December 31, 2018 | 685.10M |
| September 30, 2018 | 761.70M |
| June 30, 2018 | 772.00M |
| March 31, 2018 | 820.60M |
| December 31, 2017 | 825.20M |
| September 30, 2017 | 651.10M |
| June 30, 2017 | 541.20M |
| March 31, 2017 | 558.40M |
| December 31, 2016 | 528.10M |
| September 30, 2016 | 456.50M |
| June 30, 2016 | 475.40M |
| March 31, 2016 | 473.90M |
| December 31, 2015 | 447.00M |
| September 30, 2015 | 439.40M |
| June 30, 2015 | 257.00M |
| March 31, 2015 | 867.30M |
| December 31, 2014 | 939.40M |
| September 30, 2014 | 971.40M |
| June 30, 2014 | 1.087B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intuitive Surgical, Inc. | 3.598B |
| Stryker Corp. | 4.573B |
| Glaukos Corp. | 19.41M |
| Zimmer Biomet Holdings, Inc. | 1.159B |
| Inspire Medical Systems, Inc. | 97.89M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 570.30M |
| Cash from Investing (Quarterly) | -256.40M |
| Cash from Financing (Quarterly) | -100.80M |
| Free Cash Flow Per Share (Quarterly) | 0.8773 |
| Free Cash Flow to Equity (Quarterly) | 506.60M |
| Free Cash Flow to Firm (Quarterly) | 506.70M |
| Free Cash Flow Yield | 2.40% |